A fully synthetic vaccine consisting of a tumor-associated glycopeptide antigen and a T-Cell epitope for the induction of a highly specific humoral immune response

被引：109

作者：

Dziadek, S

Hobel, A

Schmitt, E

Kunz, H

机构：

[1] Johannes Gutenberg Univ Mainz, Inst Organ Chem, D-55128 Mainz, Germany

[2] Johannes Gutenberg Univ Mainz, Inst Immunol, D-55101 Mainz, Germany

来源：

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION | 2005年 / 44卷 / 46期

关键词：

antigens; antitumor agents; glycopeptides; synthetic vaccines; T-cell epitope;

D O I：

10.1002/anie.200501594

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

(Figure Presented) On target: With the fully synthetic vaccine 1 consisting of a tumor-associated sialyl-Tn glycopeptide antigen from the epithelial mucin MUC1 and a T-cell epitope from ovalbumin, a strong, highly specific immune response (IgG) directed against the glycopeptide antigen was induced in a mouse thereby realizing the most important requirement for the development of synthetic vaccines for the initiation of the body's own immune defense against tumors. © 2005 Wiley-VCH Verlag GmbH & Co. KGaA.

引用

页码：7630 / 7635

页数：6

共 50 条

[41] AJP001, a novel helper T-cell epitope, induces a humoral immune response with activation of innate immunity when included in a peptide vaccine
Tenma, Akiko
Nakagami, Hironori
Tomioka, Hideki
Sakaguchi, Makoto
Ide, Ryoko
Koriyama, Hiroshi
Hayashi, Hiroki
Shimamura, Munehisa
Rakugi, Hiromi
Morishita, Ryuichi
FASEB BIOADVANCES, 2019, 1 (12) : 760 - 772
[42] Immunodominance and Functional Alterations of Tumor-Associated Antigen-Specific CD8+ T-Cell Responses in Hepatocellular Carcinoma
Flecken, Tobias
Schmidt, Nathalie
Hild, Sandra
Gostick, Emma
Drognitz, Oliver
Zeiser, Robert
Schemmer, Peter
Bruns, Helge
Eiermann, Thomas
Price, David A.
Blum, Hubert E.
Neumann-Haefelin, Christoph
Thimme, Robert
HEPATOLOGY, 2014, 59 (04) : 1415 - 1426
[43] Induction of a T helper cell response against the tumor-associated antigen HER-2/neu using dendritic cells
Metzger, J
zum Büschenfelde, CM
Nicklisch, N
Rose-John, S
Peschel, C
Bernhard, H
EUROPEAN JOURNAL OF CANCER, 1999, 35 : S29 - S29
[44] Requirement of tumor-associated antigen-specific CD4+ T cells for an efficient dendritic cell vaccine in antitumor immunotherapy
Simon, Thomas
Fonteneau, Jean-Francois
Gregoire, Marc
IMMUNOTHERAPY, 2013, 5 (06) : 565 - 567
[45] T-cell recognition of tumor-associated carbohydrates: The nature of the glycan moiety plays a decisive role in determining glycopeptide immunogenicity
GalliStampino, L
Meinjohanns, E
Frische, K
Meldal, M
Jensen, T
Werdelin, O
Mouritsen, S
CANCER RESEARCH, 1997, 57 (15) : 3214 - 3222
[46] Therapeutic protein deimmunization by T-cell epitope removal: antigen-specific immune responses in vitro and in vivo
Asgari, Saeme
Ebrahim-Habibi, Azadeh
Mahdavi, Mehdi
Choopani, Mohammad
Mirzahoseini, Hasan
APMIS, 2017, 125 (06) : 544 - 552
[47] The immune response to class I-associated tumor-specific cutaneous T-cell lymphoma antigens
Berger, CL
Wang, N
Christensen, I
Longley, J
Heald, P
Edelson, RL
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 107 (03) : 392 - 397
[48] Expression of tumor-associated Thomsen-Friedenreich antigen (T Ag) in Helicobacter pylori and modulation of T Ag specific immune response in infected individuals
Klaamas, K
Kurtenkov, O
Rittenhouse-Olson, K
Brjalin, V
Miljukhina, L
Shljapnikova, L
Engstrand, L
IMMUNOLOGICAL INVESTIGATIONS, 2002, 31 (3-4) : 191 - 204
[49] EPITOPE-SPECIFIC ANTIBODY FEEDBACK-REGULATION OF THE HUMORAL IMMUNE-RESPONSE AGAINST SHEEP ERYTHROCYTES INVITRO - SPECIFIC EFFECTS OF ANTI-ANTIGEN ANTIBODY VS NONSPECIFIC T-CELL ACTIVITIES
ZUBLER, RH
JOURNAL OF IMMUNOLOGY, 1981, 126 (02): : 557 - 562
[50] Humoral immune response to tumor-associated antigen Ubiquilin 1 (UBQLN1) and its tumor-promoting potential in lung cancer
Wang, Yulin
Ouyang, Songyun
Liu, Man
Si, Qiufang
Zhang, Xue
Zhang, Xiuzhi
Li, Jiaqi
Wang, Peng
Ye, Hua
Shi, Jianxiang
Song, Chunhua
Wang, Kaijuan
Dai, Liping
BMC CANCER, 2024, 24 (01)

← 1 2 3 4 5 →